Horizon Pharma Ord (HZNP) 19.00 $HZNP Horizon (HZNP)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Horizon Pharma Ord (HZNP) 19.00 $HZNP

Horizon (HZNP) Stock Up on Ravicti Label Expansion Filing
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 9:11AM CDT
Horizon Pharma (HZNP) announced that it is looking to expand the approved age range for Ravicti for chronic management of urea cycle disorders in the U.S.
ANIP: 56.37 (-0.14), HZNP: 19.00 (+0.29), RTRX: 18.53 (-0.12), BMY: 75.22 (-0.06)

Horizon Pharma plc Submits Supplemental New Drug Application for RAVICTI(R) (glycerol phenylbutyrate) Oral Liquid to Expand Age Range for Management of Urea Cycle Disorders
Marketwired - Wed Jun 29, 6:00AM CDT
The Company Has Also Initiated a European Managed Access Program for RAVICTI
HZNP: 19.00 (+0.29)

Horizon Pharma plc Added to Russell 2000(R) and 3000(R) Indexes
Marketwired - Mon Jun 27, 3:15PM CDT
DUBLIN, IRELAND--(Marketwired - Jun 27, 2016) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced it has been added to the U.S. Russell 2000® and 3000® Indexes, effective today, as part of the 2016 Russell indexes reconstitution.
HZNP: 19.00 (+0.29)

Drugs - Generic Stocks Technical Data - Allergan, Mylan, Horizon Pharma, and Celator Pharma
PR Newswire - Fri Jun 17, 7:00AM CDT
On Thursday, June 16, 2016, the NASDAQ Composite ended the trading session at 4,844.92, up 0.21%; the Dow Jones Industrial Average advanced 0.53% to finish at 17,733.10; and the S&P 500 closed at 2,077.99, up 0.31%. The gains were broad based as seven out of nine sectors ended the session in positive. Stock-Callers.com has initiated coverage on the following equities: Allergan PLC (NYSE: AGN), Mylan N.V. (NASDAQ: MYL), Horizon Pharma PLC (NASDAQ: HZNP), and Celator Pharmaceuticals Inc. (NASDAQ: CPXX). Learn more about these stocks by accessing their free trade alerts at:
CPXX: 30.25 (+0.01), AGN: 240.45 (-0.14), HZNP: 19.00 (+0.29), MYL: 44.81 (+0.27)

Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting
PR Newswire - Tue Jun 07, 2:42PM CDT
Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI) a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced that at its 2016 Annual Meeting of Shareholders held in Toronto, all nominees listed in the management proxy circular dated May 4, 2016 were elected as directors of the Company.
NRI.TO: 7.10 (-0.20), HZNP: 19.00 (+0.29)

Nuvo Pharmaceuticals(TM) Announces Director Election Results of its Annual General Meeting
CNW Group - Tue Jun 07, 2:42PM CDT
Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI) a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced that at its 2016 Annual Meeting of Shareholders held in Toronto, all nominees listed in the management proxy circular dated May 4, 2016 were elected as directors of the Company.
NRI.TO: 7.10 (-0.20), HZNP: 19.00 (+0.29)

Horizon Pharma plc to Participate in Jefferies 2016 Healthcare Conference
Marketwired - Thu Jun 02, 6:00AM CDT
DUBLIN, IRELAND--(Marketwired - Jun 2, 2016) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will present at the Jefferies 2016 Healthcare Conference at 2 p.m. EDT on June 9, 2016 in New York City, NY.
HZNP: 19.00 (+0.29)

Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets
Marketwire Canada - Wed Jun 01, 6:00AM CDT
Will Represent the Fifteenth U.S. Patent Listed in the Orange Book for VIMOVO
HZNP: 19.00 (+0.29), ARZ.TO: 4.85 (+0.15), ARLZ: 3.71 (+0.10)

Biotech Stock Roundup: XenoPort Soars on Acquisition Deal, AbbVie Crohn's Disease Drug Fares Well
Arpita Dutt - Zacks Investment Research - Wed May 25, 2:02PM CDT
Deals and acquisitions were in focus this week in the biotech sector while AbbVie's (ABBV) recently in-licensed candidate fared well in a mid-stage study.
VRTX: 89.77 (+0.81), HZNP: 19.00 (+0.29), ICPT: 153.44 (+1.71), ABBV: 64.55 (+0.39), ACOR: 25.59 (-0.62), BIOD: 0.30 (-0.01), XNPT: 7.07 (+0.05)

Horizon (HZNP) to Buy Global Rights to Actimmune, Stock Down
Zacks Equity Research - Zacks Investment Research - Fri May 20, 8:10AM CDT
Horizon Pharma (HZNP) will acquire global rights to Actimmune from Boehringer Ingelheim. The deal is expected to close by year end.
ANIP: 56.37 (-0.14), HZNP: 19.00 (+0.29), RTRX: 18.53 (-0.12), BMY: 75.22 (-0.06)

Horizon Pharma plc to Acquire Worldwide Rights to Interferon Gamma-1b From Boehringer Ingelheim International GmbH
Marketwire Canada - Thu May 19, 6:00AM CDT
Also Licenses Rights to Patents and Pending Applications Covering Methods for Treating Friedreich's Ataxia With Interferon Gamma-1b; Company Currently Owns the Rights to Interferon Gamma-1b Under the Trade Name ACTIMMUNE(R) in the United States, Canada and Japan
HZNP: 19.00 (+0.29)

Horizon Pharma plc to Participate in UBS Global Healthcare Conference
Marketwire Canada - Wed May 18, 4:45PM CDT
DUBLIN, IRELAND--(Marketwired - May 18, 2016) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that Timothy P. Walbert, chairman, president and chief executive officer, will present at the UBS Global Healthcare Conference at 11 a.m. EDT on May 25, 2016 in New York City, NY.
HZNP: 19.00 (+0.29)

Horizon Pharma plc Announces That Marilyn Vetter Honored as a 2016 Healthcare Businesswomen's Association Luminary
Marketwired - Thu May 12, 7:00AM CDT
DUBLIN, IRELAND--(Marketwired - May 12, 2016) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that Marilyn Vetter, vice president, government and public affairs, has been named a 2016 Healthcare Businesswomen's Association (HBA) Luminary. Marilyn will be honored today at the 27th annual Woman of the Year event in New York.
HZNP: 19.00 (+0.29)

Horizon Pharma plc Announces Settlement of PENNSAID(R) (diclofenac sodium topical solution) 2% w/w Patent Litigation With Teligent, Inc.
Marketwire Canada - Thu May 12, 6:00AM CDT
DUBLIN, IRELAND--(Marketwired - May 12, 2016) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that its affiliates have entered into a settlement and license agreement with Teligent, Inc. to resolve pending patent litigation involving PENNSAID® (diclofenac sodium topical solution) 2% w/w (PENNSAID® 2%).
HZNP: 19.00 (+0.29), TLGT: 8.13 (+0.06)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 150

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 183

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 233

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 122

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 304

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 217

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 154

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 238

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 201

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 211

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: C3.ai Faces Class Action Over Financial Disclosures

Updated Category News Views 198

Investors Alert Regarding Class Action Lawsuit Against C3.ai NEW YORK and NEW ORLEANS — Investors of C3.ai, Inc. are encouraged to act swiftly regarding a class action lawsuit. If you have experienced losses exceeding $100,000 and purchased the company’s securities between February 26, 2025, and August 8, 2025, you may be eligible to participate as lead plaintiff in...

Continue Reading
XCMG's Global Expansion: Building Bridges Down Under and Beyond

Updated Category News Views 58

Trade Missions and Machinery: A Strategic Move Trade winds are blowing from Xuzhou to Jakarta and Sydney, with XCMG Group's top brass spearheading efforts. Chairman Yang Dongsheng and his band of delegates are making big waves, strengthening ties with Indonesia and Australia. Now, any seasoned trader will tell you to keep an eye on these moves—it's all about setting the...

Continue Reading
Local Expertise Wins in Luxury Real Estate Market

Updated Category News Views 48

Why Local Expertise Still Matters Technology has transformed how we shop for real estate, but when it comes to luxury, Jud Whitlock isn't buying the idea that local knowledge doesn't matter. This guy's been around the block, and in a recent HelloNation piece, he dropped some truths that every global buyer and seller ought to take to heart. If you're thinking a snazzy app...

Continue Reading
Hewlett Packard Enterprise's Bold Move with AI Day and Juniper

Updated Category News Views 90

Hewlett Packard Enterprise Sets the Stage for AI Day with Exciting Developments Hewlett Packard Enterprise Co (HPE) is making headlines as it sets out on an ambitious path by acquiring Juniper Networks for a significant $14 billion. This pivotal acquisition underscores the company's commitment to advancing its position in the technology market, particularly in the realms...

Continue Reading
BRT Realty Trust Achieves 52-Week Milestone: Here’s What It Means

Updated Category News Views 153

BRT Realty Trust: A Closer Look at Recent Success Recently, BRT Realty Trust (NYSE: BRT) made headlines by hitting a remarkable 52-week high, with shares trading at $20.12. This achievement signifies a strong upward trend for the real estate investment trust, particularly known for its focus on multi-family properties. In the past year alone, BRT Realty Trust has seen its...

Continue Reading